MAPT and Alzheimer disease: The changed expression profile of miRNAs in patients with AD and its association with the pathology of AD have been postulated for many years, including the revealed significant role of some miRNAs in modulating synaptic plasticity, Tau and β-amyloid peptide toxicity [33–35].